The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 160.00
Bid: 155.00
Ask: 165.00
Change: 0.00 (0.00%)
Spread: 10.00 (6.452%)
Open: 160.00
High: 160.00
Low: 160.00
Prev. Close: 160.00
TIDE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

27 Sep 2022 07:00

RNS Number : 7033A
Crimson Tide PLC
27 September 2022
 
27 September 2022 Crimson Tide plc Interim results for the six months ended 30 June 2022 Crimson Tide plc ("Crimson Tide" or "the Company"), the provider of the mpro5 solution is pleased to announce its unaudited interim results for the six months ended 30 June 2022. 

Financial headlines

 

· Revenue increase of 15.3% to £2.3m (H1 2021: £2.0m)

· Annual recurring revenue (ARR) increase of 22.7% to £4.4m (H1 2021: £3.6m)

· Gross margin of 84.5% (H1 2021: 84.9%)

· EBITDA loss post-investment programme of £(0.3)m (H1 2021: +£0.3m)

 

Operational highlights

 

· Consistent growth in core recurring revenue

· Contract wins since period end will contribute to H2 ARR

· Resilient gross margins

· Continued investment in product development, marketing activity and US opportunity using funds raised

· Substantial progress on single-platform strategy

 

 Barrie Whipp, Founder and Chairman, commented,

 

"Our focus on high-margin, long-term contracted revenue continues, and we are on track with our key internal metrics. Our single platform strategy should allow us to add further annual recurring revenue in wider vertical and geographic sectors."

 

About the Company

Crimson Tide's mpro5 platform allows organisations to complete simple or complex processes and compliance obligations on any modern smart device. The Company's high-margin, long-term contracted revenues model underpins growth in a wide range of vertical and geographic markets. mpro5 is provided as a fully interactive service, including reports, alerting, KPIs and sensor data, as well as integrating with clients' back-end systems. mpro5 quickly embeds itself into our clients' operations.

 

Enquiries:

Crimson Tide plc

Barrie Whipp / Jacqueline Daniell

 

+44 1892 542444

finnCap Ltd (Nominated Adviser and Broker)

Corporate Finance: Julian Blunt / James Thompson

+44 20 7220 0500

 

Corporate Broking: Andrew Burdis

 

Alma PR (Financial PR)

Josh Royston

+44 7780 901979

 

 

Chairman's Statement

 

 

 

The half year to 30th June represented a one-year milestone from our fundraise in 2021. The purpose of the raise was to prosecute opportunities across our business, and I am pleased to report good progress in those areas.

 

It is important firstly to highlight mpro5's core enterprise business, which continues to add high-quality, high-margin business on long-term contracts. Our core ARR metric moved ahead well year on year, up 22.7% to £4.4m (H1 2021: £3.6m). Our performance at the revenue line was equally solid, with growth coming from a range of existing, expanding customer requirements and new transactions. Contract wins were particularly pleasing in continental Europe under our Master Services Agreement with Compass Group. Our high margin ensures that much of the revenue translates to cash, with mpro5 revenues bolstering our opportunities to invest in growth. Our bottom line will continue to be impacted in the short term by higher than normal investment expenditure utilising the funds raised in 2021, albeit slightly less than expected in the period with some delayed marketing expenditure and delays in recruitment.

 

Our investment in our "one platform, many apps" strategy is progressing very well. This platform will not only support mpro5 but also future development of our other applications in small business, healthcare and other vertical markets. A new web client will be rolled out in the coming months, followed by a new version of our mpro5 mobile app in Q1 2023. These technologies will fast-track further developments to market, using the latest technologies and a single repository code base for the first time.

 

Our app for small businesses is currently undergoing its first iteration app store release. Extensive feedback has informed the functionality of this release and will flow through into incremental releases in the coming year. We believe the small business market we addressed when we started our mobile solutions will find the app store version compelling. Our experience marketing this application gives us insight into opportunities for mpro5 and our new healthcare app, which is next in line in our one platform, many app strategy.

 

Our business in the United States is now established with four full-time staff in Raleigh, NC. A pipeline has been established, and we are working hard to expand this and close our first contracts. Our US operation is also progressing well with our relationship with Cisco, where we are demonstrating mpro5's IoT capabilities.

 

It is appropriate to mention that two significant contract wins closed in the three weeks following the half year. These contracts have been under discussion for some months and will positively impact the second half and notably the ARR. It is also important to mention that, in August, Jacqueline Daniell assumed the role of Group CEO, and I am very optimistic about further progress under Jacqui's leadership of the executive team.

 

Our focus on high-margin, long-term contracted revenue continues, and we are on track with our key internal metrics. Our single platform strategy should allow us to add further ARR in wider vertical and geographic sectors.

 

 

Barrie WhippFounder and Chairman27 September 2022

 

 

Chief Executive's Statement

 

Crimson Tide's performance during the first half of 2022 has really begun to illustrate the business growth we have planned. Although we are still only in the relatively early stages of post-fundraise investment deployment, a lot has been achieved and solid foundations set allowing all areas of the business to effectively scale.

 

Investment in the Development Roadmap has already achieved technology scalability. Working inside a single flexible platform means that we can support new applications for new markets, currently manifested in the mpro5 platform being made available to smaller businesses. Investment in the product means we can offer the features, functionality and usability that our customers want. Our internal teams can work more efficiently and empower users thus also scaling the service element of our offering. Insights and metrics measuring the customer experience of our product and service have long demonstrated loyalty and suggest a brand of world-class potential. This year's growth in revenue, long-term contract commitments and low churn are the recent validations of the value of the product.

 

Continued investment in marketing has resulted in a significant increase in sales pipelines, both in the UK and the US. An initial outbound marketing focus at the beginning of the year launched a digital program of activity, content creation and partner collateral. Later in the year, this was complemented with an inbound approach, resulting in go-to-market strategies for a range of business sectors and territories. The overall effect has seen specific deal activity being directly attributed to marketing investment.

 

The outlook is extremely promising. A focused organisation with a unique product and service combination, a strong pipeline and visibility of revenue means we can be confident about reaching our targets and longer-term ambitions.

 

 

Jacqueline Daniell

Group CEO

27 September 2022

Financial Review

 

Financial indicator

Six months ended 30 June 2022£'000

Six months ended 30 June 2021£'000

Year ended 31 December 2021£'000

Revenue

2,324

2,015

4,114

Gross profit

1,964

1,711

3,483

EBITDA

(344)

588

183

(Loss)/Profit before tax

(860)

286

(582)

Annual recurring revenue (ARR)

4,368

3,600

3,804

Cash

3,731

6,596

5,736

Churn rate

1%

1.4%

2.4%

Revenue

Revenue increased by 15.3% compared to the corresponding period of 2021, while Annual Recurring Revenue (ARR) increased by 22.7% to £4.4m. Contracted long-term revenue exceeded 90% of total revenue and revenue churn remained negligible. The geographic split of revenue remains consistent with the prior year, with a UK weighting of 91% of revenue (H1 2021: 92%).

 

Cashflow and liquidity

Cash at the period-end was £3.7m (H1 2021: £6.6m). Operating cash flows before movements in working capital for the period was an outflow of £376k (H1 2021: £530k inflow). This outflow is in line with management expectations and the Company's previous communication following the capital fundraise in 2021. The funds were utilised on additional marketing expenditure and territorial expansion in North America to enable further revenue growth.

 

Lease liabilities

The company entered into a new office lease agreement at the beginning of 2022. This created a lease liability of £883k with a related Right-of-Use asset. The lease liability will be settled, and the related asset depreciated, over a 5-year period.

 

Intangible assets

Software development costs of £771k (H1 2021: £259k) were capitalised during the period under review, while amortisation amounted to £203k (H1 2021: £123k). The value of the capitalised software intangible asset at period-end was £2.8m (H1 2021: £1.8m).

Other intangible assets related to goodwill, website development costs and incremental contract costs.

 

Loss before taxation

The Company made a loss before taxation of £860k (H1: 2021 £286k profit). The loss was in line with management expectations and arose due to the investments in sales and marketing and territorial expansion in North America as mentioned above. The current market forecast is for the Company to return to profitability in 2024.

 

Earnings per share

Basic and diluted loss per share was 0.13p (H1 2021: 0.05p earnings) during the period under review. 16.7 million share options outstanding were not included in the calculation of diluted earnings per share because they are anti-dilutive in terms of IAS 33.

 Crimson Tide plc

Condensed Consolidated Statement of Profit or Loss

for the 6 months to 30 June 2022

 

Unaudited

6 Months

ended

30 June

2022

 

Restated Unaudited

6 Months

ended

30 June

2021

 

Audited

12 Months

ended 31

December

2021

 

£000

 

£000

 

£000

 

 

 

 

 

 

 

 

Revenue

2,324

2,015

4,114

 

Cost of Sales

(360)

(304)

(631)

 

 

Gross Profit

1,964

1,711

3,483

 

Other income

5

123

142

 

Operating expenses

(2,313)

(1,246)

(3,442)

 

Operating (loss)/profit

(344)

588

183

 

Finance costs

(21)

(12)

(10)

 

Depreciation

(194)

(108)

(185)

 

Amortisation

(301)

(182)

(570)

 

 

(Loss)/Profit before taxation

(860)

 

286

 

(582)

 

Taxation

-

-

(32)

 

 

(Loss)/Profit for the period attributable to equity holders of the parent

 

(860)

 

 

 

286

 

(614)

 

 

(Loss)/Earnings per share

Unaudited

6 Months

ended

30 June

2022

 

Unaudited

6 Months

ended

30 June

2021

 

Audited

12 Months

ended 31

December

2021

 

Basic (pence)

(0.13)

0.05

(0.10)

 

Diluted (pence)

(0.13)

0.05

(0.10)

 

 

 

 

 

 

 

Condensed Consolidated Statement of Comprehensive Income

for the 6 months to 30 June 2022

 

Unaudited

6 Months

ended

30 June

2022

 

Unaudited

6 Months

ended

30 June

2021

 

Audited

12 Months

ended 31

December

2021

 

£000

£000

£000

 

 

(Loss)/Profit for the period

(860)

286

(614)

 

 

Other comprehensive income/(loss) for period:

 

Exchange differences on translating foreign operations

(14)

1

2

 

 

 

Total comprehensive (loss)/profit recognised in the period and attributable to equity holders of parent

 

(874)

 

287

 

(612)

 

 

Condensed Consolidated Statement of Financial Position at 30 June 2022

 

Unaudited

As at

30 June

2022

 

Restated Unaudited

As at

30 June

2021

 

Audited

As at 31 December 2021

£000

 

£000

 

£000

ASSETS

Non-current assets

Intangible assets

3,928

2,959

3,282

Property, plant & equipment

260

189

167

Right-of-use asset

795

64

36

Deferred tax asset

-

32

-

Total non-current assets

4,983

3,244

3,485

 

Current assets

Inventories

-

6

-

Trade and other receivables

1,406

1,038

1,079

Cash and cash equivalents

3,731

6,596

5,736

Total current assets

5,137

7,640

6,815

 

Total assets

 

10,120

 

10,884

 

10,300

 

LIABILITIES

Current liabilities

Trade and other payables

1,071

741

1,160

Borrowings

1

7

5

Lease liabilities

136

134

98

Total current liabilities

1,208

882

1,263

 

Non-current liabilities

Lease liabilities

749

64

-

Total non-current liabilities

749

64

-

 

Total liabilities

1,957

946

1,263

Net assets

8,163

 

9,938

 

9,037

EQUITY

Share capital

657

657

657

Share premium

5,590

5,590

5,590

Other reserves

467

481

481

Reverse acquisition reserve

(5,244)

(5,244)

(5,244)

Retained earnings

6,693

8,454

7,553

Total equity

8,163

 

9,938

 

9,037

 

Condensed Consolidated Statement of Changes in Equity

 

Six-month period ended 30 June 2022 (Unaudited)

 

 

 

 

 

 

Share capital

 

 

Share premium

 

 

Other reserves

Reverse acquisi-tion reserve

 

 

Retained earnings

 

 

 

Total

 

£000

£000

£000

£000

£000

£000

Balance at 31 December 2021

657

5,590

481

(5,244)

7,553

9,037

Loss for the period

-

-

-

-

(860)

(860)

Translation movement

-

-

(14)

-

-

(14)

Balance at

30 June 2022

 

657

 

5,590

 

467

 

(5,244)

 

6,693

 

8,163

 

Six-month period ended 30 June 2021 (Unaudited)

 

 

 

Share capital

 

 

Share premium

 

 

Other reserves

Reverse acquisi-tion reserve

 

 

Retained earnings

 

 

 

Total

 

£000

£000

£000

£000

£000

£000

Balance at 31 December 2020

457

148

479

(5,244)

8,167

4,007

Shares issued

200

5,442

-

-

-

5,642

Profit for the period

-

-

-

-

286

286

Translation movement

-

-

2

-

1

3

Balance at

30 June 2021

 

657

 

5,590

 

481

 

(5,244)

 

8,454

 

9,938

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Statement of Changes in Equity

 

Year ended 31 December 2021 (Audited)

 

 

 

Share capital

 

 

Share premium

 

 

Other reserves

Reverse acquisi-tion reserve

 

 

Retained earnings

 

 

 

Total

 

£000

£000

£000

£000

£000

£000

 

Balance at 1 January 2021

457

148

479

(5,244)

8,167

4,007

Shares issued

200

5,442

-

-

-

5,642

Profit for the period

-

-

-

-

(614)

(614)

Translation movement

-

-

2

-

-

2

Balance at

31 December 2021

 

657

 

5,590

 

481

 

(5,244)

 

7,553

 

9,037

Condensed Consolidated Statement of Cash flows

For the 6 months to 30 June 2022

 

Unaudited

6 Months

ended

30 June

2022

Restated Unaudited

6 Months

ended

30 June

2021

Audited

12 Months

ended

31 December

2021

 

£000

£000

 

£000

Cash flows from operating activities

(Loss)/Profit before tax

(860)

286

(582)

Adjustments for:

Amortisation of Intangible Assets

301

123

570

Depreciation of property, plant and equipment

103

80

129

Depreciation of right-of-use assets

91

28

56

Unrealised currency translation movement

(14)

1

2

Finance costs

3

12

10

Operating cash flows before movement in working capital and provisions

(376)

530

185

Decrease in inventories

-

-

6

Increase in trade and other receivables

(327)

(253)

(215)

(Decrease)/increase in trade and other payables

(89)

(166)

253

Cash (utilised)/generated by operations

(792)

111

229

Finance costs

(21)

(10)

(10)

Net cash (used in)/ generated from operating activities

 

(813)

101

 

219

 

Cash flows from investing activities

Purchases of property, plant and equipment

(196)

(34)

(61)

Purchases of other intangible assets

(176)

-

(90)

Development expenditure capitalised

(771)

(259)

(964)

Net cash used in investing activities

(1,143

)

(293

 

(1,115)

Cash flows from financing activities

Net proceeds from share issues

-

5,696

5,642

Repayments of borrowings

(4)

(6)

(8)

Repayments of lease liability

(45)

(77)

(177)

Net cash (used in)/ from financing activities

(49)

 

5,613

 

(5,457)

Net movement in cash and cash equivalents

(2,005)

5,421

 

4,561

 

Net cash and cash equivalents at beginning of period

5,736

1,175

1,175

Net cash and cash equivalents at end of period

3,731

 

6,596

 

5,736

Crimson Tide Plc

 

Notes to the Unaudited Interim Results for the 6 months ended 30 June 2022

 

1. General information and basis of preparation

 

Crimson Tide plc is a public company, limited by shares, and incorporated and domiciled in the United Kingdom. The Company's shares are publicly traded on the London Stock Exchange's AIM market. The address of its registered office is Brockbourne House, 77 Mt. Ephraim, Tunbridge Wells, Kent, TN4 8BS.

 

Basis of preparation

The condensed consolidated interim financial statements ("interim financial statements") have been prepared using accounting policies that are consistent with those applied in the previously published financial statements for the year ended 31 December 2021, which have been prepared in accordance with IFRS as adopted by the UK.

 

The information for the period ended 30 June 2022 has neither been audited nor reviewed and does not constitute statutory accounts as defined in section 434 of the Companies Act 2006.

 

The interim financial statements should be read in conjunction with the consolidated financial statements for the year ended 31 December 2021. A copy of the statutory accounts for that period has been delivered to the Registrar of Companies. The auditor's report on those accounts was unqualified and did not contain statements under section 498 (2) or (3) of the Companies Act 2006.

 

Going concern

The interim financial statements are prepared on the going concern basis. The financial position of the Company, its cash flows and liquidity position are described in the interim financial statement and notes. The Company has the financial resources to continue in operation for the foreseeable future, a period of not less than 12 months from the date of this report.

 

2. Revenue and operating segments

 

The Group has three main regional centres of operation; one in the UK, the others in Ireland and the United States but the Group's resources, including capital, human and non-current assets are utilised across the Group irrespective of where they are based or originate from. The Board is the chief operating decision maker ("CODM"). The CODM allocates these resources based on revenue generation, which due to its high margin nature and the Group's reasonably fixed overheads, in turn drives profitability and cashflow generation. The Board consider it most meaningful to monitor financial results and KPIs for the consolidated Group, and decisions are made by the Board accordingly.

 

In due consideration of the requirements of IFRS 8 Operating Segments, the Board consider segmental reporting by (i) business activity, by turnover, and (ii) region, by turnover to be appropriate. Business activity is best split between (i) the strategic focus of the business, i.e. mobility solutions and the resulting development services that emanate from that, (ii) non-core software solutions, including reselling third party software and related development and support services, and (iii) hardware sales to existing customers.

 

Segment information for the reporting periods is as follows:

 

 

 

 

 

 Unaudited

 6 Months

ended

30 June

2022

£000

 

 

Unaudited

 6 Months

ended

30 June

2021

£000

 

 

Audited

 12 Months

ended 31

December

2021

£000

 

Revenue by business activity

Mobility solutions and related development

2,109

1,837

3,766

Software consultancy

215

178

348

2,324

2,015

4,114

 

 

Revenue can be further analysed by geographic reason as follows:

 

 

 

 Unaudited

 6 Months

ended

30 June

2022

£000

 

 

Unaudited

 6 Months

ended

30 June

2021

£000

 

 

Audited

 12 Months

ended 31

December

2021

£000

 

Revenue by geographic region

UK

2,123

1,855

3,735

European Union

201

160

379

2,324

 

 

2,015

4,114

 

 

3. Intangible assets

 

 

Enterprise development expenditure

 

Consumer focused development expenditure

 

Website develop-ment costs

 

 

Incremental contract costs

 

 

 

Goodwill

 

 

 

Total

 

£000

£000

£000

£000

£000

£000

 

Cost

At 1 January 2022

2,937

479

18

742

799

4,975

Additions

324

447

74

102

-

947

At 30 June 2022

3,261

926

92

844

799

5,922

 

 

 

 

 

 

Enterprise development expenditure

 

Consumer focused development expenditure

 

Website develop-ment costs

 

 

Incremental contract costs

 

 

 

Goodwill

 

 

 

Total

 

£000

£000

£000

£000

£000

£000

 

Amortisation and impairment

At 1 January 2022

(1,197)

- -

-

(496)

-

(1,693)

Charge for the period

(203)

-

(10)

(88)

-

(301)

At 30 June 2022

(1,400)

-

(10)

(584)

-

(1,994)

 

 

Carrying amount at 30 June 2022

1,861

926

82

260

799

3,928

Carrying amount at 30 June 2021

1,778

-

-

382

799

2,959

 

 

 

4. Earnings per share

 

The calculation of the basic earnings per share is based on the profit attributable to ordinary shareholders and the weighted average number of ordinary shares in issue during the period.

 

The calculation of the diluted earnings per share is based on the profit per share attributable to ordinary shareholders and the weighted average number of ordinary shares that would be in issue, assuming conversion of all dilutive potential ordinary shares into ordinary shares. 

 

Reconciliations of the profit and weighted average number of ordinary shares used in the calculation are set out below:

 

 

 

 Unaudited

 6 Months

ended

30 June

2022

 

 

Unaudited

 6 Months

ended

30 June

2021

 

 

Audited

 12 Months

ended 31

December

2021

 

Earnings per share

Reported (loss)/profit (£000)

(860)

286

(614)

Reported basic earnings per share (pence)

(0.13)

0.05

(0.10)

Reported diluted earnings per share (pence)

(0.13)

0.05

(0.10)

 

 

Unaudited

 6 Months

ended

30 June

2022

 

 

Unaudited

 6 Months

ended

30 June

2021

 

 

Audited

 12 Months

ended 31

December

2021

 

No. '000

No. '000

No. '000

Weighted average number of ordinary shares

Shares in issue at start of period

657,486

457,486

457,486

Effect of shares issued during the period*

-

76,243

138,630

Weighted average number of ordinary

shares for basic EPS

 

657,486

 

533,729

 

596,116

Effect of share options outstanding

-

291

-

Weighted average number of ordinary

shares for diluted EPS

 

657,486

 

534,020

 

596,116

 

*200 million ordinary shares were issued on 23 April 2021.

 

At 30 June 2022 there were 16,700,000 (30 June 2021: 16,700,000; 31 December 2021: 16,700,000) share options outstanding. These share options were not included in the calculation of diluted earnings per share for the period ended 30 June 2022 and the year ended 31 December 2021 because they are anti-dilutive in terms of IAS 33.

 

 

5. Prior period restatement

 

During the 2021 financial year, it was identified that under IFRS 15, costs that are incremental to obtaining a contract should be capitalised. There was therefore a reclassification applied from prepayments to intangible assets of £246,218 (2020: £357,138). The impact of this had £nil impact on reserves and £nil impact on total assets.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR SESFMMEESEIU
Date   Source Headline
17th Apr 202410:05 amRNSBoard Changes
17th Apr 20247:00 amRNSPreliminary Results to 31 December 2023
23rd Jan 20247:00 amRNSTrading Update
28th Nov 20237:00 amRNSTrading Update
31st Oct 202311:45 amRNSResult of GM, Share Consolidation & TVR
10th Oct 20237:00 amRNSContract increases and extensions
6th Oct 20237:00 amRNSFurther re: Proposed Share Consolidation
5th Oct 20237:00 amRNSProposed Share Consolidation
26th Sep 20237:00 amRNSDirector dealing
25th Sep 20237:00 amRNSInterim Results
20th Sep 20237:00 amRNSContract Win
14th Sep 20237:00 amRNSStrengthened Operating Board
20th Jun 20234:20 pmRNSResult of AGM and Statement
31st May 20237:00 amRNSBoard changes
31st May 20237:00 amRNSPosting of Annual Report and Notice of AGM
10th May 20232:10 pmRNSDirectorate Change
4th May 20237:00 amRNSContract Win and Renewals
12th Apr 20237:00 amRNSPreliminary Results
5th Apr 20237:00 amRNSContract Win
1st Mar 20237:00 amRNSNotice of Results and Investor Presentation
7th Feb 20232:00 pmRNSHolding(s) in Company
6th Feb 20233:55 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSContract Win
18th Jan 20237:00 amRNSTrading Update
4th Jan 20235:00 pmRNSHolding(s) in Company
1st Dec 20227:00 amRNSDirector dealing
17th Nov 20227:00 amRNSSignificant contract expansion and extension
27th Sep 20227:00 amRNSInterim Results
25th Aug 20227:00 amRNSDirector Dealing
3rd Aug 20227:00 amRNSChange of Auditor
2nd Aug 20227:00 amRNSBoard Changes
25th Jul 20227:00 amRNSContract Win
19th Jul 20227:00 amRNSMultiyear contract win with major wholesaler
30th Jun 202211:27 amRNSResults of AGM & Statement
16th Jun 20224:30 pmRNSAnnual Report and Notice of AGM
7th Apr 20227:00 amRNSPreliminary Results
10th Feb 20227:00 amRNSContract Win and Strategic Partnership
3rd Feb 20227:00 amRNSTrading Update
7th Dec 20217:00 amRNSMaster Service Agreement with Compass Group
12th Nov 20217:00 amRNSDirectorate Change
11th Oct 202110:59 amRNSPDMR Dealing
28th Sep 20217:00 amRNSInterim Results
29th Jun 20213:08 pmRNSResult of AGM
16th Jun 20217:00 amRNSNorth America Appointment
4th Jun 20217:00 amRNSAnnual Report and Notice of AGM
4th May 20212:22 pmRNSTotal Voting Rights
28th Apr 202110:34 amRNSHolding(s) in Company
27th Apr 20217:00 amRNSHolding(s) in Company
26th Apr 20217:00 amRNSHolding(s) in Company
23rd Apr 20214:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.